Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenichi Hirata
Orally Administered Dipeptidyl Peptidase-4 Inhibitor (Alogliptin) Prevents Abdominal Aortic Aneurysm Formation Through an Antioxidant Effect in Rats
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Related publications
Suppression of Abdominal Aortic Aneurysm Formation in Mice by Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor
Journal of Atherosclerosis and Thrombosis
Biochemistry
Internal Medicine
Cardiovascular Medicine
Cardiology
Dipeptidyl-Peptidase-4 Inhibitor, Alogliptin, Attenuates Arterial Inflammation and Neointimal Formation After Injury in Low-Density Lipoprotein (LDL) Receptor-Deficient Mice
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina Through VE-cadherin Phosphorylation
Scientific Reports
Multidisciplinary
Effect of Vildagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Cardiac Hypertrophy Induced by Chronic Beta-Adrenergic Stimulation in Rats
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Dipeptidyl Peptidase-4 (DPP-4; CD26)
Science-Business eXchange
Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Abdominal Aortic Aneurysm: An Update
